All the docs so vocal in their opposition to regulated compounds get what they want
Reported Issues: Consumers report: That the supplement did not lead to weight loss or appetite suppression as advertised That the product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements are promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Experiencing adverse side effects such as stomach pain, bloating, nausea, or heart palpitations Why Individuals Should Be Concerned: Potential claims include: Economic loss Safety risk False advertising Product defect Performance vs
Across our addiction and health-behaviors research, were advancing personalized strategies new statistical methods to untangle polysubstance use, brain-based biomarkers to guide care, and tech-in-the-wild experiments that ground lab insights in everyday life. The ongoing research is uncovering how neural pathways and the brains reward system drive substance use disorders, and highlighting new therapies like GLP-1 receptor agonists to curb cravings
While DHAR function in the ascorbate-glutathione pathway remains an outstanding candidate as a GSSG-generating enzyme, data from biochemical, transcriptomic and reverse genetics studies all suggest that other enzymes may contribute
4.4 Neuroinflammation The neurotoxic environment created by synthetic cathinones activates microglia and astrocytes, leading to the release of proinflammatory cytokines, such as IL-1 and TNF-
